ACLARION, INC. Accounts Payable, Other, Current
ACLARION, INC. (ACON) had Accounts Payable, Other, Current of $544.74 thousand as of 2023-03-31, per its 10-Q filed 2023-07-03.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableOtherCurrent · last filed 2023-07-03
- 2023-03-31: Accounts Payable, Other, Current $544.74K.
- 2022-12-31: Accounts Payable, Other, Current $462.20K; Accounts Payable, Other, Current as first filed $457.56K.
- 2021-12-31: Accounts Payable, Other, Current $1.06M.
| Period end | Accounts Payable, Other, Current | Accounts Payable, Other, Current as first filed |
|---|---|---|
| 2023-03-31 | $544.74K 10-Q · filed 2023-07-03 | |
| 2022-12-31 | $462.20K 10-Q · filed 2023-07-03 | $457.56K 10-K · filed 2023-02-27 |
| 2021-12-31 | $1.06M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |